HOBDEN ADRIAN N 4
4 · Myriad Pharmaceuticals, Inc. · Filed Mar 19, 2010
Insider Transaction Report
Form 4
HOBDEN ADRIAN N
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2010-03-18$4.41/sh+20,000$88,200→ 134,782 total
Footnotes (1)
- [F1]The shares were purchased in multiple transactions at prices ranging from $4.39 to $4.45 per share. The price reported above is the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.